Factor analysis of leptin, adiponectin effect and resistin during bronchial asthma by Lalaeva, Тatiana M. et al.
© St. Petersburg State University, 2020
 https://doi.org/10.21638/spbu11.2020.301 173




Factor analysis of leptin, adiponectin effect 
and resistin during bronchial asthma
T. M. Lalaeva, V. N. Mineev, V. I. Trofimov
Pavlov First St. Petersburg State Medical University,  
6–8, ul. L’va Tolstogo, St. Petersburg, 197022, Russian Federation
For citation: Lalaeva T. M., Mineev V. N., Trofimov V. I. Factor analysis of leptin, adiponectin effect 
and resistin during bronchial asthma Vestnik of Saint Petersburg University. Medicine, 2020, vol. 15, 
issue 3, pp. 173–176. https://doi.org/10.21638/spbu11.2020.301
To date, the participation of particular adipokines (leptin, adiponectin, resistin) in the patho-
genesis of bronchial asthma has been well studied, however, their interaction, in particular 
their cooperative effect on the course of the disease, has not been practically studied. The 
aim of the study is to identify the effect of the cooperative interaction of key adipokines on 
the course of bronchial asthma, depending on the pathogenetic variant of the disease. Factor 
analysis was used to analyze the data from the study of the levels of leptin, adiponectin, resis-
tin in 56 patients with bronchial asthma. Factor analysis made it possible to identify 3 factors. 
Factor 1 reflects the direct effect of leptin signaling on the severity of bronchial asthma, to 
a lesser extent on the exacerbation of the disease. In this case, the adiponectin component, 
with a high negative factor load, is associated with the severity of the course and the phase of 
bronchial asthma. Factor 2 reflects the direct effect of another adipokine resistin on the sever-
ity of bronchial asthma, but we draw attention to the fact that the resistin component with a 
large positive factor loading is associated with a non-allergic variant of bronchial asthma and 
exacerbation of the disease. Factor analysis revealed a fundamentally different pathogenetic 
role in relation to the severity of bronchial asthma of such adipokines as leptin and resistin in 
different variants of the disease.
Keywords: leptin, adiponectin, resistin, bronchial asthma, severity of the course, factor ana- 
lysis. 
To date, the participation of adipokines in the pathogenesis of bronchial asthma has 
been well studied, and this concerns the participation of individual specific adipokines 
(leptin [1], adiponectin [2], resistin [3]). Nevertheless, in the body, both a healthy person 
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and a patient with bronchial asthma, there is undoubtedly a complex interaction (a kind of 
complex microset of signaling molecules) of key adipokines, which ultimately determines 
the vector of normal or pathological regulatory changes.
We have previously made an attempt to develop an analytical approach to identifying 
the nature of the interaction of a number of adipokines using integral indicators in an al-
lergic variant of bronchial asthma [4]. The idea of [4] a certain specialization of the effects 
of adipokines in allergic bronchial asthma was put forward: apelin signaling is mainly 
involved in the regulation of bronchial resistance, and adiponectin signaling is involved in 
the regulation of the activity of inflammation cells.
As the goal of this article, the task was formulated to identify the influence in the 
cooperative interaction of key adipokines on the course of bronchial asthma, depending 
on the pathogenetic variant of the disease.
For this purpose, the well-known method of mathematical analysis — factor analy-
sis — was used. As is well known, factor analysis helps to find hidden, but objectively 
existing regularity of the investigated process.
Materials and methods
56 patients with bronchial asthma were examined. Diagnosis was established accord-
ing to criteria and standards of international consensus on AD diagnosis and treatment 
(GINA, 2012).
All examined patients of BA were in the hospital therapy clinic named after M. V. Cer-
norutsky of the Pavlov First St. Petersburg State Medical University.
The database is provided by associate professor, Doctor of Medical Sciences T. M. La-
laeva, the results of studies of adipokine levels are presented in the dissertation work for 
the degree of Doctor of Medical Sciences [5].
Leptin, adiponectin, resistin, as well as the soluble plasma leptin receptor were de-
termined by the enzyme immunosorbent method (ELISA) using a standard sandwich-
based protocol. Reagent kits “Leptin ELISA” (DRG Diagnostics, Germany), “Adiponectin 
ELISA” (DRG Diagnostics, Germany), “Human Resistin ELISA” (DRG Diagnostics, Ger-
many) were used. The analysis of adipokines was carried out on ELISA immunoanalyzer 
Uniplan-M version 1.04 with a wavelength of 450 nm.
Statistical analysis of research results was carried out using the SPSS program for 
Windows (Statistical Package for the Social Science) — (Russified version 21.0).
Results and discussion
The factor analysis includes (Table) both values of leptin levels, leptin receptor expres-
sion, adiponectin, resistin and body mass index, reflecting to a certain extent the content 
of adipose tissue, and key characteristics of the course of bronchial asthma (pathogenetic 
variant of the disease, severity of the course, phase of the disease).
It should be emphasized that through the factor analysis, the expediency of using the 
factor model was checked: Bartlett’s sphericity criterion (p < 0.0002); the adequacy test of 
the Kaiser-Meyer-Olkin sample was 0.604, which indicates the acceptable adequacy of the 
factor analysis we applied.
As can be seen from Table, 3 factors were identified by factor analysis.
Вестник СПбГУ. Медицина. 2020. Т. 15. Вып. 3 175
















Leptin (ng/ml) 0.756 Resistin (ng/ml) 0.532
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Adiponectin (μg/ml) –0.517 Adiponectin (μg/ml) 0.423 Leptin receptor (ng/ml) –0.112
















0.194 Leptin (ng/ml) –0.128 Adiponectin (μg/ml) –0.073





Factor 1 reflects the direct effect of leptin signaling on the severity of the course of 
bronchial asthma, to a lesser extent on the exacerbation of the disease. The adiponectin 
component with high negative factor load is associated with flow severity and phase of 
bronchial asthma.
We emphasize that the components of leptin signaling with a high factor load (Fac-
tor 1) are associated with an allergic variant of the disease.
In contrast, Factor 2 reflects the direct effect of another adipokine resistin on the se-
verity of bronchial asthma course, but note that a resistin component with a large positive 
factor load is associated with a nonallergic variant of bronchial asthma and exacerbation 
of the disease.
It is very interesting that the adiponectin component as well as the resistin compo-
nent in Factor 2 directly correlates with the severity of bronchial asthma, and with the 
variant of bronchial asthma of nonallergic genesis.
Factor 3, which characterizes bronchial asthma as such (severity of course, phasicity), 
does not provide additional significant information to solve our goal, emphasizing only 
the fact that the severity of course and phasicity of the disease are influenced by other 
causes not related to adipokines and adipose tissue.
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Thus, factor analysis revealed an apparently fundamentally different pathogenetic 
role in relation to the severity of the course of bronchial asthma of adipokines such as 
leptin and resistin in various disease variants.
Undoubtedly, in the human body, these adipokines as hormones of adipose tissue, 
like all other hormones, interact with each other at the level of membrane receptors, the 
form of interaction can be different (synergism, antagonism, permissive action).
Unfortunately, there are no direct studies regarding the problem of the interaction of 
adipokines, although, based on the already known mechanisms of individual adipokines, 
it is possible to assume a certain nature of such interaction. So, in our study, the antago-
nistic effect of leptin and adiponectin in relation to such an important characteristic of 
bronchial asthma as the severity of the course is very clearly revealed.
It is also important that if, in an allergic variant of bronchial asthma, leptin and re-
sistin have some synergy with respect to the formation of the severity of the course of the 
disease, then in a nonallergic version, these adipokines are somewhat antagonistic in ef-
fect on the severity of the course.
Further research work remains to be done on the accumulation of data explaining 
these similarities and differences in these influences.
Our factorial analysis of these studies of adipokines in bronchial asthma — an analy-
sis that, as already noted, helps to find hidden but objectively existing regularity of the 
studied process in complex microsets, allows us to once again confirm our idea of special-
izing the effects of adipokines, despite their general direction of their effects in different 
variants of bronchial asthma.
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